Search research articles
Contact Us
Filters
Showing results (181-190 of 199) with videos related to
Page
of 20
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)
|
April 1, 1997
Home parenteral nutrition and vitamin B12 status
D Lambert, B Messing, S Benhayoun, et al.
Journal of Internal Medicine
|
February 1, 1994
Thymoma with immunodeficiency (Good's syndrome) associated with selective cobalamin malabsorption and benign IgM-kappa gammopathy
C Jeandel, I Gastin, H Blain, et al.
Neuroscience Letters
|
July 13, 2000
Inhibition of vitamin B12 metabolism by OH-cobalamin c-lactam in rat oligodendrocytes in culture: a model for studying neuropathy due to vitamin B12 deficiency
I E Sponne, D Gaire, S P Stabler, et al.
Allergie Et Immunologie
|
April 29, 1999
Histamine content does not influence the tolerance of wine in normal subjects
G Kanny, T Bauza, S Frémont, et al.
Synapse (New York, N.Y.)
|
May 20, 2000
Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat
A Gobert, J M Rivet, F Lejeune, et al.
The European Journal of Neuroscience
|
April 13, 2000
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram
M J Millan, A Gobert, J M Rivet, et al.
Journal of Internal Medicine
|
September 1, 1996
Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy
A Bellou, I Aimone-Gastin, J D De Korwin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol
M J Millan, A Gobert, A Newman-Tancredi, et al.
The British Journal of Nutrition
|
July 27, 2000
The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects
A Chango, F Boisson, F Barbé, et al.
Digestion
|
January 1, 1997
Alcoholic cirrhosis and cobalamin metabolism
D Lambert, S Benhayoun, C Adjalla, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 199) with videos related to
Sort By:
Page
of 20
Nutrition (Burbank, Los Angeles County, Calif.)
|
April 1, 1997
Home parenteral nutrition and vitamin B12 status
D Lambert, B Messing, S Benhayoun, et al.
Journal of Internal Medicine
|
February 1, 1994
Thymoma with immunodeficiency (Good's syndrome) associated with selective cobalamin malabsorption and benign IgM-kappa gammopathy
C Jeandel, I Gastin, H Blain, et al.
Neuroscience Letters
|
July 13, 2000
Inhibition of vitamin B12 metabolism by OH-cobalamin c-lactam in rat oligodendrocytes in culture: a model for studying neuropathy due to vitamin B12 deficiency
I E Sponne, D Gaire, S P Stabler, et al.
Allergie Et Immunologie
|
April 29, 1999
Histamine content does not influence the tolerance of wine in normal subjects
G Kanny, T Bauza, S Frémont, et al.
Synapse (New York, N.Y.)
|
May 20, 2000
Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat
A Gobert, J M Rivet, F Lejeune, et al.
The European Journal of Neuroscience
|
April 13, 2000
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram
M J Millan, A Gobert, J M Rivet, et al.
Journal of Internal Medicine
|
September 1, 1996
Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy
A Bellou, I Aimone-Gastin, J D De Korwin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol
M J Millan, A Gobert, A Newman-Tancredi, et al.
The British Journal of Nutrition
|
July 27, 2000
The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects
A Chango, F Boisson, F Barbé, et al.
Digestion
|
January 1, 1997
Alcoholic cirrhosis and cobalamin metabolism
D Lambert, S Benhayoun, C Adjalla, et al.
Page
of 20